Results 191 to 200 of about 104,696 (276)

The EQ-5D-5L and Minimal Important Change in Long COVID. [PDF]

Adv Rehabil Sci Pract
Smith AB, Greenwood DC, Milne R, Ormerod M, Sivan M.   +4 more
europepmc   +1 more source

A Care Pathway for the Treatment of IBD Reduces Healthcare Costs and Is Cost‐Effective: Results of the Multicentre IBD Value Study

Alimentary Pharmacology &Therapeutics, EarlyView.
This study provides real‐world evidence that implementing an advanced therapy care pathway for patients with IBD leads to significant healthcare cost savings without compromising quality of life. These findings support broader implementation of care pathways in the management of patients with chronic conditions to optimise care delivery and resource ...
Elyke H. Visser, Martijn. A. Oude Voshaar, Reinier C. A. van Linschoten, Alexander G. L. Bodelier, Claire Fitzpatrick, Vincent de Jonge, Hestia Vermeulen, K. Evelyne Verweij, Sanne van der Wiel, Daniëlle van der Horst, C. Janneke van der Woude, R. L. West, D. van Noord   +12 more
wiley   +1 more source

Assessing the dimensionality of the EQ-HWB-25 alongside EQ-5D-5L, QOL-ACC and ASCOT in an older adult population. [PDF]

Qual Life Res
Bahrampour M, Akanksha A, Kuharic M, Viney R, Mulhern B.   +4 more
europepmc   +1 more source

Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH‐TC study

British Journal of Haematology, EarlyView.
Summary This prospective study evaluated the incidence and dynamics of frailty in 156 adults with lymphoproliferative syndromes undergoing autologous haematopoietic stem cell transplantation (HSCT). Frailty was assessed using the haematopoietic cell transplantation (HCT) frailty scale in patients from 15 Spanish institutions at initial consultation ...
Javier Cornago, Mónica Baile, Marina Acera, Laura Fox, María del Mar Pérez‐Artigas, Ana Santamaría, María del Carmen Quintela, Andrés Sánchez‐Salinas, Joaquina M. Salmerón, Verónica Illana, Zahra Abdallahi‐Lefdil, Laura Pardo, Laura Solán, José Luis López‐Lorenzo, Sara Fernández‐Luis, Leddy Patricia Vega, Sara Villar, Patricia Beorlegui‐Murillo, Mónica Molina, Albert Esquirol, Isabel Izquierdo, Julia Ribes, Alberto Mussetti, Esperanza Lavilla, Olga Alda, Javier López‐Marín, Leyre Bento, Silvia Filaferro, Pascual Balsalobre, Anna Sureda, María Queralt Salas   +30 more
wiley   +1 more source

Economic Evaluation of the RETURN Intervention to Increase Routine Dental Attendance Among Disadvantaged Adults: Net Health Benefit (QALYs) and Patient Cost Outcomes From a Randomised Controlled Trial

Community Dentistry and Oral Epidemiology, EarlyView.
ABSTRACT Objectives Routine dental attendance is associated with better health outcomes, yet those from disadvantaged backgrounds are more likely to seek problem‐driven, episodic care. The RETURN intervention, a brief behavioural intervention delivered by dental nurses in urgent care, was designed to support urgent care users to take up planned dental ...
Tayamika Zabula, Victoria Lowers, Dan Howdon, Rebecca Harris   +3 more
wiley   +1 more source

Health-related quality of life in amputees with a microprocessor-controlled prosthetic knee measured by the EQ-5D-5L. [PDF]

Can Prosthet Orthot J
Brüggenjürgen B, Kannenberg A, Stukenborg-Colsman CIM, Hahn A.   +3 more
europepmc   +1 more source

EQ-5D-5L Valuation Study in Taiwan [PDF]

Value in Health, 2018
H Lin, C Li, F Lin, J Chang, C Gau, N Luo, AS Pickard, JM Ramos-Goñi, C Tang, C Hsu   +9 more
openaire   +1 more source

Comparison of Allergic Rhinitis Treatments on Utilities and Quality of Life: A MASK‐air Study

Clinical &Experimental Allergy, EarlyView.
This mHealth study has shown that fixed combinations of intranasal antihistamines and corticosteroids were associated with higher quality of life than oral antihistamines and intranasal antihistamines. Both intranasal corticosteroids and oral antihistamines were associated with higher quality of life than intranasal antihistamines.
Nuno Lourenço‐Silva, Bernardo Sousa‐Pinto, Antonio Bognanni, Ana Margarida Pereira, João Coutinho‐Almeida, Rita Amaral, Luisa Brussino, Mattia Giovannini, Bilun Gemicioglu, Violeta Kvedariene, Desiree E. Larenas‐Linnemann, Manuel Marques‐Cruz, Nikolaos G. Papadopoulos, Nhân Pham‐Thi, Frederico S. Regateiro, Sanna K. Toppila‐Salmi, Boleslaw Samolinski, Joaquin Sastre, Luís Taborda‐Barata, Arunas Valiulis, Leticia de las Vecillas, Maria Teresa Ventura, Oliver Pfaar, João A. Fonseca, Torsten Zuberbier, Ludger Klimek, Jean Bousquet, Rafael José Vieira   +27 more
wiley   +1 more source

Impact of Osilodrostat on Health‐Related Quality of Life in Cushing's Disease: Analysis of Patient‐Reported Outcomes From the Phase III LINC 3 and LINC 4 Clinical Trials

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Evaluate the effects of osilodrostat short‐ and long‐term treatment on health‐related quality of life (HRQoL) in Cushing's disease. Design LINC 3 and LINC 4 studies (pooled analysis). Patients 185 patients (mean baseline total scores: Cushing's Quality of Life [CushingQoL], 44.0; Beck Depression Inventory II [BDI‐II], 15.6; EuroQol ...
John Newell‐Price, Beverly M. K. Biller, Maria Fleseriu, Beatrice Gueron, Grzegorz Binowski, Anna Paćkowska, Mônica R. Gadelha   +6 more
wiley   +1 more source

Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE. [PDF]

PLoS One
Schouten AEM, Frederix GWJ, Stuiver MM, Fischer F, Hiensch AE, Cromm K, Canaud B, Strippoli GFM, May AM, van der Meulen MP, PREFERABLE-EFFECT Scientific Committee, and the CONVINCE Scientific Committee.   +11 more
europepmc   +1 more source